Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease

Jarrett RJ (1994) Why is insulin not a risk factor for coronary heart disease? Diabetologia 37: 945–947 Stout RW (1990) Insulin and atheroma: 20-yr perspective. Diabetes Care 13: 631–654 Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1495–1607 Hollenbeck G, Reaven GM (1987) Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64: 1169–1173 Reaven GM, Hollenbeck CB, Chen Y-DI (1989) Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32: 52–55 Reaven GM, Brand RJ, Chen Y-DI, Mathur AK, Goldfine I (1993) Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes 42: 1324–1332 Haffner SM, Stem MP, Hazuda HP, Mitchell BD, Patterson JK (1990) Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? J Amer Med Assoc 263: 2893–2898 Landin K, Tengvory L, Smith U (1990) Elevated fibrinogen and plasminogen activator (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 227: 273–278 Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 3: 416–422 Laws A, Reaven GM (1993) Insulin resistance and risk factors for coronary heart disease. In: Ferrannini E (ed) Clinical endocrinology and metabolism: insulin resistance and disease. Baillière Tindall, London, pp 1063–1078 Reaven GM, Chen Y-DI (1988) Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes/Metab Rev 4: 639–652 Reaven GM, Lerner RL, Stern MP, Farquhar JW (1967) Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46: 1756–1767 Olefsky JM, Farquhar JW, Reaven GM (1974) Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57: 551–560 Tobey TA, Greenfield M, Kraemer F, Reaven GM (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165–171 Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstack J, Raskin P (1988) Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37: 982–987 Olefsky JM, Reaven GM, Farquhar JW (1974) Effects of weight reduction on obesity: studies of carbohydrate and lipid metabolism, J Clin Invest 53: 64–76 Farquhar JW, Frank A, Gross RC, Reaven GM (1966) Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man. J Clin Invest 45: 1648–1656 Zavaroni I, Dall'Aglio E, Alpi O et al. (1985) Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55: 259–266 Laws A, Reaven GM (1992) Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Int Med 231: 25–30 Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WS, Krauss RM (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 260: 1917–1921 Patsch JR, Miesenböck G, Hopferwieser T et al. (1992) Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 12: 1336–1345 Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM (1993) Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 92: 141–146 Chen Y-DI, Swami S, Skowronski R, Coulston A, Reaven GM (1993) Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 76: 172–177 Miller GJ, Miller NE (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heartdisease. Lancet I: 16–19 Castelli WP, Doyle JT, Gordon T et al. HDL cholesterol and other lipids in coronary heart disease. Circulation 55: 767–772 Manninen V, Tenkanen L, Koskinen P et al. (1992) Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study: implications for treatment. Circulation 85: 37–45 Assmann G, Schulte H (1992) Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 70: 733–737 Hulley SB, Rosenman RH, Bawol RD, Brand RJ (1980) Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med 302: 1383–1389 Criqui MH, Heiss G, Cohn R et al. (1993) Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328: 1220–1225 Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11: 2–14 Reaven GM (1993) Are triglycerides important as a risk factor for coronary disease? Heart Dis Stroke 2: 44–48 Laws A, King AC, Haskell W, Reaven GM (1991) Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arterioscler Thromb 11: 1636–1642 Juhan-Vague I, Alessi MC, Vague P (1991) Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 34: 457–462 Potter van Loon BJ, Kluft C, Radder JK, Blankenstein MA, Meinders AE (1993) The cardiovascular risk factor plasminogen activator inhibitor type I is related to insulin resistance. Metabolism 42: 945–949 Juhan-Vague I, Thompson SG, Jespersen J, on Behalf of the ECAT Angina Pectoris Study Group (1993) Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. Arterioscler Thromb 13: 1865–1873 Hamsten A, Wiman B, Defaire U, Blomback M (1985) Increased plasma level of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313: 1557–1563 Jarrett RJ (1992) In defence of insulin: a critique of syndrome X. Lancet 340: 469–471 Reaven GM (1991) Relationship between insulin resistance and hypertension. Diabetes Care 14: 33–38 Ferrari P, Weidmann P, Shaw S et al. (1991) Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 91: 589–596 Facchini F, Chen Y-DI, Clinkingbeard C, Jeppesen J Reaven GM (1992) Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 5: 694–699 Shamiss A, Carroll J, Rosenthal T (1992) Insulin resistance in secondary hypertension. Am J Hypertens 5: 26–28 Hwang I-S, Ho H, Hoffmann BB, Reaven GM (1987) Fructose-induced insulin and hypertension in rats. Hypertension 10: 512–516 Reaven GM, Ho H, Hoffman BB (1988) Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 12: 129–132 Reaven GM, Ho H, Hoffmann BB (1989) Somatostatin inhibition of fructose-induced hypertension. Hypertension 14: 117–120 Reaven GM, Chang H (1991) Relationship between blood pressure, insulin concentration, and insulin action in SHR and WKY rats. Am J Hypertens 4: 34–38 Reaven GM, Twersky J, Chang H (1991) Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension 18: 630–635 Dall'Aglio E, Tosini P, Ferrari P, Zavaroni I, Passeri M, Reaven GM (1991) Abnormalities of insulin and lipid metabolism in Milan hypertensive rats. Am J Hypertens 4: 773–775 Anderson EA, Mark AL (1993) The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 21: 136–141 Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt A, Gaillard CA (1990) Chronic hyperinsulinemia and blood pressure. Hypertension 15: 519–527 Brands MW, Hildebrandt DA, Mizelle HL, Hall JE (1991) Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 260: R764-R768 Saad M, Lillioja S, Myomba BL et al. (1991) Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324: 733–739 Falkner B, Hulman S, Tennenbaum J, Kushner H (1990) Insulin resistance and blood pressure in young black men. Hypertension 16: 706–711 Falkner B, Hulman S, Kushner H (1993) Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension 22: 18–25 Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary-heart-disease risk and impaired glucose tolerance. Lancet i: 1373–1376 Vaccaro O, Ruth KJ, Stamler J (1992) Relationship of postload plasma glucose to mortality with 19-yr follow-up. Diabetes Care 13: 1328–1334 Sheu WH-H, Jeng C-Y, Shieh S-M et al. (1992) Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens 5: 444–448